EXPERT FORUM
Addressing Challenges in Analytical Validation: Understanding ICH Q2(R2) and Integration with ICH Q14
Part 1: Understanding the ICH Q2 Guideline (21 May, 2025)
Part 2: Key Challenges and Solutions in Adapting to ICH Q2(R2) (28 May, 2025)
Your registration is successful, and you will receive an email explaining how to watch and attend the presentation.
If you know a colleague who would benefit from this presentation, use the form to invite them.
Please submit your questions for our presenters or panellists anytime before the live broadcast.
We suggest adding the event to your calendar by using the button below.
Presenters / Panellists
Dr. Joachim Ermer
Founder & Owner
Ermer Quality Consulting (Germany)
Dr. Pierre Lebrun
Director, Principal Consultant, Data Strategy and Quantitative Sciences
Cencora – PharmaLex (Belgium)
Moderators
Prof. Dr. Cari Sänger-van de Griend
Expert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.
Dr. Ewoud van Tricht
Expert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.
Brought to you by:
Resources
[COMING]
Contact Us
If you have any questions about the event, don’t hesitate to get in touch with the BioQC Team: Feedback & General Enquiry